Wednesday, 4 March 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 04 March 2026
News

BMS takes access fight to NZ

Posted 4 March 2026 AM

Fresh from an historic reimbursement win in Australia, BMS has taken the fight over the ditch, with a new report spotlighting the agonising wait times for access to innovative medicines in New Zealand.

The most damning statistics reveal delays of seven to 10 years between regulatory approval from Medsafe and funding through Pharmac, for many medicines. This compares to six to 18 months in Australia and the United Kingdom.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (10)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (16)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.